Skip to main content
Log in

Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis

  • Original Article
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Laparoscopic liver resection (LLR) has now been established as a safe and minimally invasive technique that is deemed feasible for treating hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). However, the role of LLR in treating combined hepatocellular-cholangiocarcinoma (cHCC-CC) patients has been rarely reported. This study aimed to assess the efficacy of LLR when compared with open liver resection (OLR) procedure for patients with cHCC-CC.

Methods

A total of 229 cHCC-CC patients who underwent hepatic resection (34 LLR and 195 OLR patients) from January 2014 to December 2018 in Zhongshan Hospital, Fudan University were enrolled and underwent a 1:2 propensity score matching (PSM) analysis between the LLR and OLR groups to compare perioperative and oncologic outcomes. Overall survival (OS) and recurrence-free survival (RFS) parameters were assessed by the log-rank test and the sensitivity analysis.

Results

A total of 34 LLR and 68 OLR patients were included after PSM analysis. The LLR group displayed a shorter postoperative hospital stay (6.61 vs. 8.26 days; p value < 0.001) when compared with the OLR group. No significant differences were observed in the postoperative complications’ incidence or a negative surgical margin rate between the two groups (p value = 0.409 and p value = 1.000, respectively). The aspartate aminotransferase (AST), alanine aminotransferase (ALT), and inflammatory indicators in the LLR group were significantly lower than those in the OLR group on the first and third postoperative days. Additionally, OS and RFS were comparable in both the LLR and OLR groups (p value = 0.700 and p value = 0.780, respectively), and similar results were obtained by conducting a sensitivity analysis.

Conclusion

LLR can impart less liver function damage, better inflammatory response attenuation contributing to a faster recovery, and parallel oncologic outcomes when compared with OLR. Therefore, LLR can be recommended as a safe and effective therapeutic modality for treating selected cHCC-CC patients, especially for those with small tumors in favorable location.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Seehawer M, D’Artista L, Zender L (2019) The Worst from Both Worlds: cHCC-ICC. Cancer Cell 35:823–824

    Article  CAS  PubMed  Google Scholar 

  2. Leoni S, Sansone V, Lorenzo S, Ielasi L, Tovoli F, Renzulli M, Golfieri R, Spinelli D, Piscaglia F (2020) Treatment of Combined Hepatocellular and Cholangiocarcinoma. Cancers (Basel) 12:794

    Article  CAS  PubMed  Google Scholar 

  3. Lee CH, Hsieh SY, Chang CJ, Lin YJ (2013) Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. J Gastroenterol Hepatol 28:122–127

    Article  PubMed  Google Scholar 

  4. Vilchez V, Shah MB, Daily MF, Pena L, Tzeng CW, Davenport D, Hosein PJ, Gedaly R, Maynard E (2016) Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database. HPB (Oxford) 18:29–34

    Article  PubMed  Google Scholar 

  5. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanche H, Franco D, Monges G, Belghiti J, Sa Cunha A, Laurent-Puig P, Degott C, Zucman-Rossi J (2004) Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 41:292–298

    Article  CAS  PubMed  Google Scholar 

  6. Joseph NM, Tsokos CG, Umetsu SE, Shain AH, Kelley RK, Onodera C, Bowman S, Talevich E, Ferrell LD, Kakar S, Krings G (2019) Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma. J Pathol 248:164–178

    Article  CAS  PubMed  Google Scholar 

  7. Xue R, Chen L, Zhang C, Fujita M, Li R, Yan SM, Ong CK, Liao X, Gao Q, Sasagawa S, Li Y, Wang J, Guo H, Huang QT, Zhong Q, Tan J, Qi L, Gong W, Hong Z, Li M, Zhao J, Peng T, Lu Y, Lim KHT, Boot A, Ono A, Chayama K, Zhang Z, Rozen SG, Teh BT, Wang XW, Nakagawa H, Zeng MS, Bai F, Zhang N (2019) Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes. Cancer Cell 35:932-947.e938

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Azizi AA, Hadjinicolaou AV, Goncalves C, Duckworth A, Basu B (2020) Update on the genetics of and systemic therapy options for combined hepatocellular cholangiocarcinoma. Front Oncol 10:570958

    Article  PubMed  PubMed Central  Google Scholar 

  9. Wakabayashi G, Cherqui D, Geller DA, Buell JF, Kaneko H, Han HS, Asbun H, O’Rourke N, Tanabe M, Koffron AJ, Tsung A, Soubrane O, Machado MA, Gayet B, Troisi RI, Pessaux P, Van Dam RM, Scatton O, Abu Hilal M, Belli G, Kwon CH, Edwin B, Choi GH, Aldrighetti LA, Cai X, Cleary S, Chen KH, Schon MR, Sugioka A, Tang CN, Herman P, Pekolj J, Chen XP, Dagher I, Jarnagin W, Yamamoto M, Strong R, Jagannath P, Lo CM, Clavien PA, Kokudo N, Barkun J, Strasberg SM (2015) Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg 261:619–629

    PubMed  Google Scholar 

  10. Han HS, Shehta A, Ahn S, Yoon YS, Cho JY, Choi Y (2015) Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching. J Hepatol 63:643–650

    Article  PubMed  Google Scholar 

  11. Lee W, Park JH, Kim JY, Kwag SJ, Park T, Jeong SH, Ju YT, Jung EJ, Lee YJ, Hong SC, Choi SK, Jeong CY (2016) Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Surg Endosc 30:4835–4840

    Article  PubMed  Google Scholar 

  12. Wu X, Huang Z, Lau WY, Li W, Lin P, Zhang L, Chen Y (2019) Perioperative and long-term outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with well-preserved liver function and cirrhotic background: a propensity score matching study. Surg Endosc 33:206–215

    Article  PubMed  Google Scholar 

  13. Gunasekaran G, Bekki Y, Lourdusamy V, Schwartz M (2021) Surgical treatments of hepatobiliary cancers. Hepatology 73:128–136

    Article  PubMed  Google Scholar 

  14. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242:252–259

    Article  PubMed  PubMed Central  Google Scholar 

  15. Fu XT, Tang Z, Chen JF, Shi YH, Liu WR, Gao Q, Ding GY, Song K, Wang XY, Zhou J, Fan J, Ding ZB (2021) Laparoscopic hepatectomy enhances recovery for small hepatocellular carcinoma with liver cirrhosis by postoperative inflammatory response attenuation: a propensity score matching analysis with a conventional open approach. Surg Endosc 35(2):910–920

    Article  PubMed  Google Scholar 

  16. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213

    Article  PubMed  PubMed Central  Google Scholar 

  17. Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, Han GH, Wang MQ, Liu RB, Lu LG, Ren ZG, Chen MS, Zeng ZC, Liang P, Liang CH, Chen M, Yan FH, Wang WP, Ji Y, Cheng WW, Dai CL, Jia WD, Li YM, Li YX, Liang J, Liu TS, Lv GY, Mao YL, Ren WX, Shi HC, Wang WT, Wang XY, Xing BC, Xu JM, Yang JY, Yang YF, Ye SL, Yin ZY, Zhang BH, Zhang SJ, Zhou WP, Zhu JY, Liu R, Shi YH, Xiao YS, Dai Z, Teng GJ, Cai JQ, Wang WL, Dong JH, Li Q, Shen F, Qin SK, Fan J (2018) Guidelines for diagnosis and treatment of primary liver cancer in China. Liver Cancer 7:235–260

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hwang ES, Wang X (2017) Value of propensity score matching to study surgical outcomes. Ann Surg 265:457–458

    Article  PubMed  Google Scholar 

  19. Kang TW, Kim JM, Rhim H, Lee MW, Kim YS, Lim HK, Choi D, Song KD, Kwon CH, Joh JW, Paik SW, Paik YH, Ahn JH (2015) Small hepatocellular carcinoma: radiofrequency ablation versus nonanatomic resection-propensity score analyses of long-term outcomes. Radiology 275:908–919

    Article  PubMed  Google Scholar 

  20. Ho DE, Imai K, King G, Stuart EA (2011) MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 42:1–28

    Article  Google Scholar 

  21. Der Wal WMV, Geskus RB (2011) ipw: an R package for inverse probability weighting. J Stat Softw 43:1–23

    Article  Google Scholar 

  22. Tian MX, Luo LP, Liu WR, Deng W, Yin JC, Jin L, Jiang XF, Zhou YF, Qu WF, Tang Z, Wang H, Tao CY, Fang Y, Qiu SJ, Zhou J, Liu JF, Fan J, Shi YH (2019) Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma. Cancer Manag Res 11:5187–5195

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wang T, Wang W, Zhang J, Yang X, Shen S, Wang W (2020) Development and validation of a nomogram for differentiating combined hepatocellular cholangiocarcinoma from intrahepatic cholangiocarcinoma. Front Oncol 10:598433

    Article  PubMed  PubMed Central  Google Scholar 

  24. Peng Y, Lin P, Wu L, Wan D, Zhao Y, Liang L, Ma X, Qin H, Liu Y, Li X, Wang X, He Y, Yang H (2020) Ultrasound-based radiomics analysis for preoperatively predicting different histopathological subtypes of primary liver cancer. Front Oncol 10:1646

    Article  PubMed  PubMed Central  Google Scholar 

  25. Cheng D, Cross CL, Calfee G, Kirgan D, Williams SJ, Baynosa J, St Hill CR (2019) Comparing treatment patterns of hepatocellular carcinoma at academic centers and non-academic centers within the Mountain Region. Am J Surg 218:1052–1059

    Article  PubMed  Google Scholar 

  26. Wang X, Teh CSC, Ishizawa T, Aoki T, Cavallucci D, Lee SY, Panganiban KM, Perini MV, Shah SR, Wang H, Xu Y, Suh KS, Kokudo N (2021) Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery. Ann Surg 274:97–106

    Article  PubMed  Google Scholar 

  27. Ciria R, Cherqui D, Geller DA, Briceno J, Wakabayashi G (2016) Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann Surg 263:761–777

    Article  PubMed  Google Scholar 

  28. Yamashita YI, Aishima S, Nakao Y, Yoshizumi T, Nagano H, Kuroki T, Takami Y, Ide T, Ohta M, Takatsuki M, Nanashima A, Ishii F, Kitahara K, Iino S, Beppu T, Baba H, Eguchi S (2020) Clinicopathological characteristics of combined hepatocellular cholangiocarcinoma from the viewpoint of patient prognosis after hepatic resection: high rate of early recurrence and its predictors. Hepatol Res 50:863–870

    Article  CAS  PubMed  Google Scholar 

  29. Ishii T, Ito T, Sumiyoshi S, Ogiso S, Fukumitsu K, Seo S, Taura K, Uemoto S (2020) Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma. World J Surg Oncol 18:319

    Article  PubMed  PubMed Central  Google Scholar 

  30. Wakizaka K, Yokoo H, Kamiyama T, Ohira M, Kato K, Fujii Y, Sugiyama K, Okada N, Ohata T, Nagatsu A, Shimada S, Orimo T, Kamachi H, Taketomi A (2019) Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers. J Gastroenterol Hepatol 34:1074–1080

    Article  CAS  PubMed  Google Scholar 

  31. Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380

    Article  PubMed  Google Scholar 

  32. Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17:669–680

    Article  PubMed  Google Scholar 

  33. Li DY, Zhang HB, Yang N, Quan Y, Yang GS (2013) Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series. World J Gastroenterol 19:9084–9091

    Article  PubMed  PubMed Central  Google Scholar 

  34. Kim DH, Choi DW, Choi SH, Heo JS, Kow AW (2015) Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution. Surgery 157:666–675

    Article  PubMed  Google Scholar 

  35. Xun XD, Li Q (2016) Surgical treatment of intrahepatic cholangiocarcinoma: a retrospective study of 104 cases. Cancer Biol Med 13:469–473

    Article  PubMed  PubMed Central  Google Scholar 

  36. Gerken ALH, Herrle F, Jakob J, Weiß C, Rahbari NN, Nowak K, Karthein C, Hohenberger P, Weitz J, Reißfelder C, Dobroschke JC (2020) Definition and severity grading of postoperative lymphatic leakage following inguinal lymph node dissection. Langenbecks Arch Surg 405:697–704

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We acknowledged Dr. Yining Wang for his assistance of patient collection. This work was supported by the Major Program of National Natural Science Foundation of China (No. 82090054), National Natural Science Foundation of China (No. 81772566), Clinical Research Plan of Shanghai Hospital Development Center (No. 2020CR3004A), and Natural Science Funds of Shanghai (No. 21ZR1413800).

Funding

Major Program of National Natural Science Foundation of China, No. 82090054, Xiaoying Wang, National Natural Science Foundation of China, No. 81772566, Xiaoying Wang, Clinical Research Plan of Shanghai Hospital Development Center, No. 2020CR3004A, Xiaoying Wang, Natural Science Funds of Shanghai, No. 21ZR1413800, Kai Zhu.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiao-Ying Wang.

Ethics declarations

Disclosures

Dan-Jun Song, Kai Zhu, Jin-peng Tan, Jia-Bin Cai, Min-Zhi Lv, Jie Hu, Zhen-Bin Ding, Guo-Ming Shi, Ning Ren, Xiao-Wu Huang, Ying-Hong Shi, Shuang-Jian Qiu, Qing-Hai Ye, Hui-Chuan Sun, Qiang Gao, Jian Zhou, Jia Fan, and Xiao-Ying Wang have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 45 kb)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, DJ., Zhu, K., Tan, Jp. et al. Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis. Surg Endosc 37, 967–976 (2023). https://doi.org/10.1007/s00464-022-09579-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-022-09579-y

Keywords

Navigation